ANI Pharmaceuticals (ANIP) has completed the buyout of its 3.125% perpetual royalty obligation to SWK Funding on worldwide net revenues of ...
Jefferies initiated coverage of ANI Pharmaceuticals (ANIP) with a Buy rating and $80 price target The firm expects continued momentum for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback